Barclays’s Oncorus, Inc. ONCR Stock Holding History

Barclays’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,495	Closed	-$384	–	4813
2023 Q2	$384	Hold	9,495	–	–	﹤0.01%	4393
2023 Q1	$3.27K	Hold	9,495	–	–	﹤0.01%	4860
2022 Q4	$2.4K	Sell	9,495 -866	-8%	-$492	﹤0.01%	5073
2022 Q3	$9K	Sell	10,361 -639	-6%	-$820	﹤0.01%	4373
2022 Q2	$14K	Sell	11,000 -2,111	-16%	-$2.87K	﹤0.01%	4522
2022 Q1	$23K	Buy	+13,111	New	+$36.7K	﹤0.01%	4412

Other funds holding ONCR

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Barclays's ONCR Position: Q3 2023 in Review

Barclays sold out of Oncorus, Inc. (ONCR) in Q3 2023, closing a stake of 9,495 shares — an estimated $384 sold.

Barclays first reported a position in ONCR in Q1 2022 and held it in 6 quarters. The position peaked at $23K in Q1 2022. 1 fund tracked by Wall St. Rank holds ONCR as of Q3 2023.

Barclays reported no remaining Oncorus, Inc. position as of Q3 2023 after selling out during the quarter.
Barclays sold 9,495 Oncorus, Inc. shares in Q3 2023, an estimated $384.
Barclays first reported a position in Oncorus, Inc. in Q1 2022 and held it in 6 quarters.
Barclays's Oncorus, Inc. position peaked at $23K in Q1 2022.
1 fund tracked by Wall St. Rank held Oncorus, Inc. as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.